格拉斯通投资

最新新闻

• 评级变动
  H.C. Wainwright Maintains Gain Therapeutics(GANX.US) With Buy Rating, Maintains Target Price $8
  \u5e02\u573a\u8d44\u8baf · 2026/10/5
• 评级变动
  HC Wainwright & Co. Reiterates Buy on Gain Therapeutics, Maintains $8 Price Target
  Benzinga · 2026/10/5
• 评级变动
  H.C. Wainwright Reaffirms Their Buy Rating on Gain Therapeutics (GANX)
  TipRanks · 2026/10/5
• Bitcoin, Ether Could Gain If U.S. Rate-Rise Expectations Fall -- Market Talk
  WSJ · 2026/10/6
• 公司公告
  Japan Asia Investment: (Update on Disclosure Matters) Notice of Recognition of Extraordinary Gain Following the Subsidiarization of KIC Holdings Co., Ltd.
  JPX · 2026/5/11
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Nexalin Technology, Inc. (NXL) and Gain Therapeutics (GANX)
  TipRanks · 2026/10/3
• 评级变动
  San Ke Shu (603737): Earnings Fell Short of Expectations; Going Forward, Channel Transformation and New Business Models Will Gain Momentum.
  Shenwan Hongyuan Research · 2026/9/1
• 评级变动
  Postal Savings Bank of China (601658) – 2026 H1 Report Commentary: The Second Growth Driver Continues to Gain Momentum, with Non-Interest Income Share Reaching a New High.
  Everbright Securities · 2026/8/29
• 公司公告
  C. E. Management Integrated Laboratory: Notice Regarding the Recognition of Extraordinary Losses (Impairment Losses) and Extraordinary Gains (Gain on Sale of Investment Securities)
  JPX · 2026/8/7
• 公司公告
  To enable investors to gain a more comprehensive and in-depth understanding of the company's operating performance and financial condition as presented in its 2026 interim report, the company held an earnings briefing on September 4, 2026, from 9:00 a.m. to 10:00 a.m.
  SZSI · 2026/9/7
• Corteva Stock Can Gain 50% After Post-Spin Confusion -- Barrons.com
  Barron's · 2026/10/6
• 评级变动
  SuoChen Technology (688507): Revenue posted steady growth in the first half of 2026, with its "Kaiwu" physics‑AI products continuing to gain traction.
  SDIC Securities · 2026/8/31
• 评级变动
  BTIG Maintains Gain Therapeutics(GANX.US) With Buy Rating, Maintains Target Price $5
  \u5e02\u573a\u8d44\u8baf · 2026/10/5
• 公司公告
  Alps Alpine: Notice Regarding Completion of the Sale of Shares of Nippon Seiki Co., Ltd. and Recognition of Gain on Sale of Investment Securities
  JPX · 2026/9/18
• USD/JPY struggles to gain momentum; dollar preference is tempered by intervention concerns, leading to a sluggish pace of appreciation.
  Fisco Japan · 2026/10/5
• SpaceX shares continue to gain momentum, hitting a new high since late June.
  Gelonghui Finance · 2026/10/6
• 评级变动
  Midea Group (000333): The B2B segment continues to gain momentum, while overseas OBM is unlocking new growth opportunities.
  Everbright Securities · 2026/9/1
• 公司公告
  GIKEN: In Singapore, the market for driving H‑shaped steel sheet piles is expanding, drawing attention in urban development as the advantages of the construction method and the steel material continue to gain widespread acceptance.
  JPX · 2026/7/3
• 评级变动
  Maxim Group Maintains Gain Therapeutics(GANX.US) With Buy Rating, Maintains Target Price $7
  \u5e02\u573a\u8d44\u8baf · 2026/10/3
• U.S. Natural Gas Futures Gain Ahead of Storage Data -- Market Talk
  WSJ · 2026/10/8

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。